射频消融治疗多条折返径路的心动过速12例

目的：总结实用而有效的常规消融方法,方法：回顾分析了12例具有多条折返径路的心动过速病例的电生理检查结果,总结了其消融操作流程,结果：12例中,同时具有3条房室旁道1例,2条房室旁道7例,1条房室旁道伴房室结多径路2例,房室结三径路2例,共计消融慢径2条,旁道19条（包括左侧旁道7条,右侧旁道12条,其中显性[旁道10条,隐匿性旁道9条）,结论：消融前后详细,标准的心内电生理检查可提高多折返径路心动过速的检出率。     

心动过速RR间期交替的发生机制及导管射频消融治疗

目的　分析QRS心动过速伴RR间期长短交替的发生机制及导管射频消融情况。方法　对 6例心动过速伴RR间期长短交替患者 ,常规行动态心电图及食管电生理检查。心内电生理检查提示存在房室旁路或房性心动过速伴房室结双径路 ,先进行旁路或房性心动过速的消融 ,消融成功后再进行心内电生理检查 (包括应用异丙肾上腺素进行心动过速诱发 ) ,如不能诱发心动过速则终止手术。若提示存在房室结多径路 ,则进行慢路径改良术。结果　食管电生理检查提示 :4例患者存在房室旁路伴房室结双径路 ;2例患者存在房室结三径路。心内电生理检查及消融结果显示 :3例患者为房室旁路伴房室折返性心动过速 ,成功消融后不能诱发房室结折返性心动过速 ;1例患者同时存在房室及房室结折返性心动过速 ,成功消融房室旁路后再改良慢路径 ;2例患者为房室结三径路 ,经慢径路改良后房室结传导曲线连续 ,未诱发心动过速。 6例患者无并发症发生 ,随访期间无心动过速发作。结论　室上性心动过速伴RR间期交替发生率较低 ,且均与房室结传导不连续有关。心动过速伴RR间期交替发生机制较为复杂 ,除了与房室结纵向传导的不连续有关外 ,还与其不应期密切相关。食管电生理检查与心内电生理检查相比对揭示RR间期交替的发生机制具有较高的诊断价值。     

伴RR间期交替的室上性心动过速的射频消融

目的:探讨伴RR间期交替的窄QRS波心动过速的电生理机制和射频消融策略.方法:10例伴RR间期交替的心动过速患者接受了电生理检查,明确其心动过速类型后,首先消融旁路或诱发的心动过速,如仍能诱发房室结折返性心动过速(AVNRT)则消融慢径路,并随访了解心动过速复发情况.结果:10例患者中9例为左侧游离壁旁路合并房室结双径路,消融旁路后3例诱发AVNRT,一并成功消融了慢径路,另6例没有诱发AVNRT者未再消融,1例为房室结三径路,成功消融了慢径路.在6个月～8.4年随访中,无心动过速复发.结论:伴RR间期交替的心动过速具共同特点,即存在房室结双径路.在消融基础心动过速后,如不能诱发AVNRT,可不消融慢径路.     

射频消融治疗阵发性室上性心动过速62例体会

目的总结室上性心动过速(PSVT)射频消融治疗的经验。方法左房室旁路消融二尖瓣室侧，右房室旁路消融三尖瓣房侧；房室结双径路通过下位能量递增消融法改良房室结慢径。结果房室折返型心动过速38例，左侧旁道30条右侧旁道9条，消融成功37条，成功率95％，房室结折返型心动过速24例，房室结双径路改良全部成功，成功率100％，总成功率97％。无1例复发。结论射频消融治疗室上速安全、有效、复发率低。’     

食管电生理诊断阵发性室上性心动过速

目的探讨食管电生理诊断阵发性室上性心动过速(paroxysmal supraventricular tachycardia,PSVT)及分型的准确性。方法收集经食管电生理和心内电生理检查并行射频消融治疗的PSVT42例,将两种电生理对PSVT的诊断及分型进行比较,用X2检验,以P<0.05为差异有统计学意义。结果两种电生理检查诊断房室结双径路、慢快型房室结折返性心动过速、常见的顺向型房室折返性心动过速差异无显著性,食管电生理对房室旁路的粗略定位准确性较高,但对快慢型房室结折返性心动过速、慢房室旁路参予的房室折返性心动过速与房性心动过速不易辨别。结论食管电生理诊断常见类型的PSVT与心内电生理有相似的价值,且具有无创、简便、费用低等优点;但对不常见或复杂的PSVT不易辨别。     

三磷酸腺苷对室房传导的电生理作用

目的　探讨三磷酸腺苷 (adenosine triphosphate,ATP)对房室结双径路参与的房室交界区折返性心动过速和旁路参与的房室折返性心动过速患者的室房传导的电生理作用。　方法　 39例房室交界区折返性心动过速和 6 7例房室折返性心动过速患者在右心室起搏 (频率 140次 / m in)时 ,经股静脉快速注射 ATP 2 0 mg,连续记录体表心电图和心内电图 ,观察室房传导变化。　结果　房室交界区折返性心动过速组 33例 (84.6 % )在注射 ATP后出现室房阻滞 ,其余 6例无变化。6 7例房室旁路患者在消融前 ,6 1例 (91% )室房传导无变化 ,另 6例出现室房阻滞 ,其中 2例具递减性传导 ;而在消融后 2 4例右心室起搏频率超过 16 0次 / m in,仍为 1∶ 1逆传 ,注射 ATP后 2 3例出现室房阻滞 ,仅 1例不受影响。　结论　 ATP对房室结及旁路的电生理作用不同 ,注射 ATP后出现室房阻滞对鉴别经房室结或旁路逆传有一定价值 ,是旁路消融成功的一个判别指标 ,但并不一定完全可靠     

简化射频消融方法治疗阵发性室上性心动过速120例疗效观察

房室折返性心动过速和房室结折返性心动过速是阵发性室上性心动过速(PSVT)中最常见的两种类型,其解剖基础分别为房室旁路和房室结双径路,射频消融是PSVT的首选治疗方法, 其成功率达90%以上,且副作用轻微[1].我们在PSVT(即隐匿性房室旁路和房室结双径路)电生理检查和消融过程中应用简化3导管方法,并与常规5导管方法进行比较,旨在观察简化方法的安全性和有效性.     

穿房间隔途径左侧游离壁旁路消融致心包填塞原因分析

目的:分析穿房间隔途径左侧游离壁旁路消融致心包填塞的发生率及可能原因。方法:分析2014年1月～2018年12月3个中等手术量电生理中心的1 332例室上性心动过速患者,其中男性723例,女性609例,中位年龄52 (35～61)岁。经电生理检查证实为房室结双径路折返性心动过速、左侧旁路参与的房室折返性心动过速或右侧旁路参与的房室折返性心动过速,然后再行房室旁路或者房室结双径路消融。分析左侧旁路参与的房室折返性心动过速患者,经主动脉逆行途径或者穿房间隔途径消融左侧旁路消融过程中心包填塞发生情况及可能原因。结果:1 332例患者接受1 440次射频消融术。左侧旁路参与的房室折返性心动过速453(34%)例,其中经主动脉逆行140例(31%)和穿房间隔途径313例(69%)。穿房间隔途径心包填塞发生3例(0.9%),靶点位置在左侧游离壁或左前游离壁。经心包穿刺引流后心包填塞症状缓解,无外科开胸修补发生。结论:左侧旁路射频消融相关的心包填塞发生率相对较低,原因可能与过度消融、机械操作损伤和误消融毗邻结构相关。     

房室结慢径消融后对快径前传不应期影响

<正> 房室结双径路(DAVNP)是形成房室结折返性心动过速的必须电生理基础,射频消融房室结慢径路是治疗房室结折返性心动过速(AVNRT)安全、有效的方法.射频消融慢径路后有学者发现快径路前传不应期发生改变,本文对慢径路消融后快径路前传不应期改变,探讨慢径路消融后对快径路前传不应期的影响.1 资料和方法1.1 病例选择经电生理检查证实为DAVNP伴AVNRT患者44例,其中男性21例,女性23例;年龄15～77岁,平均年龄46.77±14.89岁;病史0.6～30年,均有反复发作室上性心动过速史.无器质性心脏病证据.合并房室结快径经消融者未选入.     

三磷酸腺苷诊断房室结双径路的价值

目的评价三磷酸腺苷(ATP)试验诊断房室结双径路的价值.方法对经心内电生理研究证实的慢快型房室结折返性心动过速21例(研究组)和同期无房室结双径路征象、且不能诱发房室结折返性心动过速的14例(对照组),在心房起搏下给予递增的ATP剂量.结果研究组中17例具有房室结双径路电生理征象(包括1例心内电生理研究时无房室结双径路征象),其中1例诱发房室结回波,3例诱发房室结折返性心动过速;对照组则均不显示房室结双径路征象、房室结回波或房室结折返性心动过速.ATP试验诊断房室结双径路的敏感性为80%,特异性为93%.结论三磷酸腺苷试验诊断房室结双径路有较高的价值.     

特殊类型房室结折返性心动过速的电生理机制及其射频消融

报道２例特殊类型的房室结折返性心动过速（ＡＶＮＲＴ），１例为慢－慢型ＡＶＮＲＴ伴起始部多径路逆传；１例为两种不同电生理特性的慢径交替前传、快径逆传构成的ＡＶＮＲＴ。电生理检查均提示房室结三径路。２例病人均于冠状静脉窦口上方消融慢径改良房室结成功，心动过速不再被诱发。随访２个月心动过速均无复发。提示房室结多径路形成的特殊类型ＡＶＮＲＴ，需详细的电生理检查并仔细鉴别方能予以诊断。射频导管消融方法同典型ＡＶＮ－ＲＴ，且安全、有效。     

Clinical application of radiofrequency ablation]

I. Radiofrequency ablation of atrioventricular accessory pathway in patients with WPW syndrome: Seventeen accessory pathways in 15 patients with Wolff-Parkinson-White syndrome (WPW) were ablated with radiofrequency current. There were 15 accessory pathways located on the left side of the heart (12 left free wall, 1 posterioseptal, 1 posteriolateral and 1 midseptal) and 2 pathways on the right side (1 right free wall, 1 anterioseptal). 16 accessory pathways (94.1%) in 14 patients were permanently abolished. Plasma CK-Mb, SGOT and LDH increased moderately in 7 cases (46.7%) and decreased to normal level in 3-4 days. Conclusion: catheter ablation of accessory pathways with radiofrequency current is a safe and effective therapeutic method for patients with refractory tachycardias mediated by these pathways. II. Radiofrequency ablation of slow pathways to cure AV nodal reentrant tachycardia: Radiofrequency energy was used to selectively ablate the slow pathways in 8 patients with atrioventricular nodal reentrant tachycardia. The slow pathways in all 8 cases were ablated successfully and no episodes of tachycardia could be induced. The A-H, H-V interval and P-R interval of ECG did not change significantly. The Wenckebach points of atrioventricular node remained unchanged. The effective refractory periods of the fast pathways were shortened in 3 and prolonged in 5 cases after the procedure. There were no severe complications. No tachycardia recurred during the follow-up period between 2 weeks and 7 months.     

房室结双径路合并房室旁路的折返性心动过速及射频消融治疗

目的本研究旨在探讨房室结双径路（ＤＡＶＮＰ）合并房室旁路（ＡＰ）的电生理特征和射频消融要求。方法对２１８例阵发性室上性心动过速（ＰＳＶＴ）进行电生理检查，观察ＰＳＶＴ的前传和逆传途径，然后对ＡＰ或房室结慢径（ＳＰ）进行消融治疗。结果２１８例ＰＳＶＴ中检出ＤＡＶＮＰ＋ＡＰ１０例，检出率为４．６％。其中ＳＰ前传、ＡＰ逆传（ＳＰ－ＡＰ折返）４例，快径（ＦＰ）前传、ＡＰ逆传（ＦＰ－ＡＰ折返）１例，ＳＰ－ＡＰ折返并ＦＰ－ＡＰ折返或ＳＰ／ＦＰ交替前传折返４例，ＳＰ前传、ＦＰ逆传（ＡＰ旁观）１例。１０例患者均作ＡＰ消融，诱发房室结折返性心动过速（ＡＶＮＲＴ）的３例加作ＳＰ消融，术后随访均无复发。结论ＤＡＶＮＰ合并ＡＰ者ＡＰ均作为逆传途径，阻断ＡＰ是消融关键；ＡＰ旁观者也应作ＡＰ消融；仅有ＡＨ跳跃延长者不必接受房室结改良；ＡＰ消融者应作ＤＡＶＮＰ电生理检查。     

射频导管消融360例儿童心律失常的疗效和安全性

目的 评价射频导管消融360例儿童心律失常的疗效和安全性。方法 回顾性分析2000年1月2013年12月360例因心律失常在我院接受射频导管消融的儿童患者360(男213例、女147)例,年龄15个月14(10±3)岁,平均体质量34 kg。结果 急性期消融成功率98.9%(356/360例),4例消融失败。360例患者中,阵发性室上性心动过速308例,占85.6%,307例(99.7%)患者消融成功,其中隐匿性房室旁路伴房室折返性心动过速121例、显性旁路(预激综合征)82例、房室结折返性心动过速105例;室性心律失常42例,其中室性早搏15例(均消融成功),27例室性心动过速(其中4例并发结构性心脏病,25例消融成功);房性心律失常10例(9例消融成功,其中典型心房扑动3例,不典型心房扑动1例,局灶性房性心动过速6例)。所有患儿围术期均未出现明重要并发症。术后随访至少12个月,随访期复发率为2.2%(8/356例),其中6例经再次消融成功。结论 射频导管消融术治疗有适应证的心律失常儿童安全有效。     

Quadruple atrioventricular nodal pathways: involved in orthodromic atrioventricular reentrant tachycardia

Supraventricular tachycardia can be caused by multiple atrioventricular nodal pathways or atrioventricular accessory pathways. Herein, we report the case of a patient who was diagnosed with an orthodromic atrioventricular reentrant tachycardia that was caused by an unusual combination of quadruple atrioventricular nodal pathways and an atrioventricular accessory pathway. Radiofrequency catheter ablation of the accessory pathway successfully eliminated the arrhythmias and the patient's symptoms. Careful analysis of complete electrophysiologic studies can help in the diagnosis of such rare clinical presentations.     

Ablation of Atrioventricular nodal “slow pathway” for simultaneous treatment of coexisting atrioventricular and nodal reciprocating tachycardias

Introduction We report the case of a 49-year-old male patient with recurrent palpitations and two different supraventricular reciprocating tachycardias due to atrioventricular (AV) nodal reentry and orthodromic AV reentry sustained by a left-sided, concealed AV accessory pathway (AP). Methods and results During the baseline electrophysiological study, dual AV nodal conduction (90 ms jump) and non-decremental, eccentric, ventriculo-atrial conduction due to a left-sided, unidirectional, postero-septal AP were documented. Both typical AV nodal reentrant and orthodromic AV reentrant tachycardias were induced by programmed electrical stimulation. In both cases, shift and sustained conduction over the AV “slow pathway” were required for tachycardia induction and maintenance, respectively. Accordingly, catheter ablation was performed by targeting the AV nodal “slow pathway” first with radiofrequency current applications delivered at the inferior portion of the Koch’s triangle. Irritative, slow-rate junctional rhythm was observed during ablation. Afterward, programmed electrical stimulation demonstrated a continuous AV nodal conduction curve, persistent conduction over the AP, and only single orthodromic AV echo beat inducible under baseline condition and pharmacological stress (atropine 0.02 mg/kg i.v. bolus and continuous isoprenaline i.v. administration). Sustained reentrant tachycardias were not inducible any more. For these reasons, the procedure was stopped without any attempt to ablate the AP. After a 4 years follow-up the patient is still asymptomatic without antiarrhythmic drug usage. Conclusion AV nodal “slow pathway” ablation may abolish both typical AV nodal reentry tachycardia and orthodromic AV reentry tachycardia induction when the latter arrhythmia is dependent from AV nodal “slow pathway” conduction for induction and maintenance. This ablation strategy could be considered, under some instances (e.g. right antero-septal accessory pathways, older patients, etc), in order to reduce the procedure risks due to multiple arrhythmia substrate ablations.     

下位法射频消融慢径路改良房室结治疗室上性心动过速23例

用下位法射频消融慢径路改良房室结治疗房室结折返性心动过速(AVNRT)18例,房室折返性心动过速(AVRT)5例.AVNRT中16例为慢—快型,1例快—慢型,1例慢—快型与快—慢型并存,18例慢径路全部阻断成功.AVRT中1例显性预激,4例隐性预激,有5例慢径路和3例房室旁路消融成功.射频放电时21例出现结性心律.无严重并发症出现.AVNRT病人中随仿1—15个月有1例复发,第二次射频成功.认为下位法射频消融阻断慢径路成功率高,并发症少.     

Radiofrequency ablation in two patients with typical and atypical atrioventricular nodal reentrant tachycardias, associated with atrioventricular reentrant tachycardias.

The incidence of dual atrioventricular nodal physiology in patients with Wolff-Parkinson-White syndrome is quite frequent, but arrhythmia related to an accessory pathway and atrioventricular nodal reentrant tachycardia (AVNRT) in a single patient is less common. Two of our cases (patients aged 24 and 19 yrs) presented the rare evidence of both typical and atypical AVNRTs, associated in the first case with two other atrioventricular reentrant tachycardias (AVRTs), and in the second case with a single AVRT. Both underwent radiofrequency catheter ablation of the slow nodal pathway and of the accessory pathways in a single session, without any complications. After a 3-month follow-up, they were free from symptoms suggestive of tachycardia, without any antiarrhythmic treatment.     

儿童和青少年快速性心律失常的临床特点

研究儿童和青少年快速性心律失常的临床特点。选择 1995～ 2 0 0 2年在我院行射频消融 (RFCA)治疗的儿童和青少年快速性心律失常患者 ,共 32 1例 ,男 2 10例、女 111例 ,年龄中位数 13.4± 3.6 (1.5～ 18)岁 ;其中 ,房室折返性心动过速 (AVRT) 2 0 4例、房室结折返性心动过速 (AVNRT) 74例、特发性室性心动过速 (IVT) 35例、房性心动过速 (AT) 5例、心房扑动 (AFL) 2例、不适当窦性心动过速 (IST) 1例。记录所有病例术前未发作心动过速及心动过速发作时的体表 12导联心电图 ,结合电生理检查 ,分析其临床特点。结果 :AVRT、AVNRT和IVT分别占6 3.6 %、2 3.1%和 10 .9%。年岁较小的儿童和青少年 ,右侧旁道较多 ,随着年龄的增加 ,左侧旁道相对越来越多。B型预激合并多旁道较常见。 35例IVT ,其中 2 3例为左室IVT ;6例为右室IVT。 12例合并先天性心脏病 ;13例并发心动过速性心肌病 ,心功能及心脏大小在RFCA术后 3～ 6个月恢复正常。结论 :①AVRT、AVNRT和IVT是儿童和青少年快速性心律失常中最常见的 3种类型。②心动过速性心肌病经早期适当的治疗是可逆的。